SLC30A8
Proton-coupled zinc antiporter SLC30A8
Also known as: ZnT-8, ZNT8, ZNT8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IWU4
- Gene
- SLC30A8
- Ensembl
- ENSG00000164756
- Chromosome
- 8
- Canonical length
- 369 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles,Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a zinc efflux transporter involved in the accumulation of zinc in intracellular vesicles. This gene is expressed at a high level only in the pancreas, particularly in islets of Langerhans. The encoded protein colocalizes with insulin in the secretory pathway granules of the insulin-secreting INS-1 cells. Allelic variants of this gene exist that confer susceptibility to diabetes mellitus, noninsulin-dependent (NIDDM). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>Q8IWU4|SLC30A8
1 MEFLERTYLV NDKAAKMYAF TLESVELQQK PVNKDQCPRE RPEELESGGM YHCHSGSKPT
61 EKGANEYAYA KWKLCSASAI CFIFMIAEVV GGHIAGSLAV VTDAAHLLID LTSFLLSLFS
121 LWLSSKPPSK RLTFGWHRAE ILGALLSILC IWVVTGVLVY LACERLLYPD YQIQATVMII
181 VSSCAVAANI VLTVVLHQRC LGHNHKEVQA NASVRAAFVH ALGDLFQSIS VLISALIIYF
241 KPEYKIADPI CTFIFSILVL ASTITILKDF SILLMEGVPK SLNYSGVKEL ILAVDGVLSV
301 HSLHIWSLTM NQVILSAHVA TAASRDSQVV RREIAKALSK SFTMHSLTIQ MESPVDQDPD
361 CLFCEDPCDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC30A8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 49 nTPM
- salivary gland: 12 nTPM
- kidney: 3.8 nTPM
- testis: 1.6 nTPM
- stomach: 1 nTPM
- small intestine: 0.8 nTPM
Single-cell type
- pancreatic islet cells: 665 nCPM
- proximal tubule cells: 133 nCPM
- undifferentiated spermatogonia: 91 nCPM
- differentiating spermatogonia: 55 nCPM
- early primary spermatocytes: 47 nCPM
- late primary spermatocytes: 21 nCPM
Immune cell
- gdT-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 2.2 nTPM
- pons: 2.1 nTPM
- cerebral cortex: 1.9 nTPM
- hippocampal formation: 1.9 nTPM
- cerebellum: 1.8 nTPM
- white matter: 1.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC30A8.
Disease | ImmuneIEDB
Conditions an epitope on SLC30A8 was assayed in.
- type 1 diabetes mellitus B and T cell
- autoimmune thyroiditis B cell
- type 2 diabetes mellitus T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against SLC30A8 are reported. Each links to that disease's full target list.
Showing 2 of 3 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for SLC30A8 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
86 publications
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
2007 · Proc Natl Acad Sci U S A · RCR 17.1 · 742 citations - Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
2009 · Diabetologia · RCR 3.8 · 160 citations - A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
2008 · Diabetes · RCR 3.6 · 155 citations - Type 1 diabetes and autoimmunity.
2014 · Clin Pediatr Endocrinol · RCR 3.5 · 100 citations - Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion.
2009 · Biochem J · RCR 3.3 · 144 citations
Show 20 more of 86 total
- Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
2010 · Diabetes Care · RCR 3.1 · 116 citations - Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8.
2011 · Clin Chem · RCR 2.6 · 90 citations - The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
2010 · Diabetes Metab Res Rev · RCR 2.1 · 78 citations - The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
2011 · Autoimmunity · RCR 2 · 67 citations - ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.
2010 · Autoimmunity · RCR 2 · 71 citations - Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
2013 · Pediatr Diabetes · RCR 2 · 56 citations - SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes.
2008 · Ann N Y Acad Sci · RCR 1.8 · 72 citations - ZnT8 and type 1 diabetes.
2012 · Endocr J · RCR 1.5 · 45 citations - Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.
2023 · Diabetes Care · RCR 1.4 · 13 citations - Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
2008 · Diabetologia · RCR 1.4 · 58 citations - Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
2010 · J Clin Endocrinol Metab · RCR 1.4 · 59 citations - Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.
2011 · Clin Immunol · RCR 1.4 · 49 citations - HERV-K Envelope Protein Induces Long-Lasting Production of Autoantibodies in T1DM Patients at Onset in Comparison to ZNT8 Autoantibodies.
2022 · Pathogens · RCR 1.2 · 14 citations - Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
2012 · Autoimmunity · RCR 1.2 · 33 citations - Cell-Surface ZnT8 Antibody Prevents and Reverses Autoimmune Diabetes in Mice.
2024 · Diabetes · RCR 1.2 · 6 citations - The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.
2014 · Diabet Med · RCR 1.1 · 30 citations - Profile of Auto-antibodies (Disease Related and Other) in Children with Type 1 Diabetes.
2020 · Indian J Endocrinol Metab · RCR 1.1 · 15 citations - Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform.
2017 · Proc Natl Acad Sci U S A · RCR 1.1 · 27 citations - Importance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans.
2017 · Sci Rep · RCR 1 · 23 citations - High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
2021 · J Clin Endocrinol Metab · RCR 1 · 18 citations
Reference: B cellIEDB
6 publications
- Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin.
2016 · Sci Rep · RCR 1.5 · 33 citations - Recognition of zinc transporter 8 and MAP3865c homologous epitopes by Hashimoto's thyroiditis subjects from Sardinia: a common target with type 1 diabetes?
2014 · PLoS One · RCR 1.1 · 25 citations - Zinc transporter 8 and MAP3865c homologous epitopes are recognized at T1D onset in Sardinian children.
2013 · PLoS One · RCR 1.1 · 28 citations - Recognition of zinc transporter 8 and MAP3865c homologous epitopes by new-onset type 1 diabetes children from continental Italy.
2014 · Acta Diabetol · RCR 1 · 23 citations - Recognition of ZnT8, Proinsulin, and Homologous MAP Peptides in Sardinian Children at Risk of T1D Precedes Detection of Classical Islet Antibodies.
2016 · J Diabetes Res · RCR 0.5 · 15 citations
Show 1 more
- Detection of Mycobacterium avium subsp. paratuberculosis in Iranian patients with type 1 diabetes mellitus by PCR and ELISA.
2016 · J Infect Dev Ctries · RCR 0.5 · 8 citations
Reference: T cellIEDB
6 publications
- Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.
2018 · Sci Immunol · RCR 6.7 · 200 citations - Peptides Derived From Insulin Granule Proteins Are Targeted by CD8+ T Cells Across MHC Class I Restrictions in Humans and NOD Mice.
2020 · Diabetes · RCR 1.9 · 45 citations - Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.
2012 · Diabetologia · RCR 1.5 · 55 citations - ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
2012 · Diabetes · RCR 1.4 · 51 citations - Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.
2016 · Vaccine · RCR 0.7 · 19 citations
Show 1 more
- Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines.
2015 · Clin Immunol · RCR 0.2 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- insulin processing
- insulin secretion
- intracellular zinc ion homeostasis
- positive regulation of insulin secretion
- regulation of vesicle-mediated transport
- response to glucose
- response to interleukin-1
- response to type II interferon
- response to zinc ion
- zinc ion import across plasma membrane
- zinc ion import into organelle
- zinc ion transmembrane transport
- zinc ion transport
Molecular functions
- protein homodimerization activity
- zinc ion binding
- zinc ion transmembrane transporter activity
- zinc:proton antiporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cation efflux
- Cation efflux transmembrane domain superfamily
- Cation efflux protein, cytoplasmic domain
- Cation efflux protein, cytoplasmic domain superfamily
- Cation Diffusion Facilitator/SLC30A
- Cation efflux protein, transmembrane domain
- Cation efflux transmembrane domain
- Cation efflux protein, cytoplasmic domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC30A8 as an antibody target. Whether an autoantibody or antibody against SLC30A8 could matter depends on whether native SLC30A8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC30A8 is annotated at the cell surface, where native SLC30A8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC30A8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...